Mergers & Acquisitions Mergers & Acquisitions

Comment: Increasing constitutional challenges to US FTC adjudication could hasten Supreme Court review

Following Amgen and Horizon Therapeutics’ recent counterclaim against the US Federal Trade Commission alleging that the agency’s in-house court violates the Constitution, a blueprint has emerged for dealmakers to challenge the constitutionality of FTC proceedings. And with each additional challenge, the danger for the FTC will grow, as every decision a

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News